Cardiorenal protective effect of sodium–glucose cotransporter 2 inhibitors and mitochondrial function

Abstract

Cardiorenal protective effects of sodium–glucose cotransporter 2 inhibitors are difficult to explain. From the recent works by Takagi et al. and an expert consensus report, I suggest further works on the effects of sodium–glucose cotransporter 2inhibitors on mitochondrial function could help to understand this very interesting development.